Although STAT3 and STAT5 both play a role in the survival and multiplication of tumor cells, STAT3 stands out as a potentially effective target for cancer treatment because it served as an important player in the recruitment of stromal cells such as immune cells to the tumor microenvironment, which supports the growth of tumors [7,8]. The gene discussed is STAT5A; the disease is neoplasm.